Company Filing History:
1 out of 4,316 
1 out of 135 
1 out of 832,912 Years Active: 2015-2019
Title: Innovations of Peng-Chun Chen in Microfluidic Technology.
Introduction
Peng-Chun Chen is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of microfluidics, particularly in the area of sperm selection and acquisition. With a total of two patents to his name, his work has the potential to impact reproductive technologies.
Latest Patents
One of his latest patents is titled "Microfluidic chips for acquiring sperms with high motility, productions and applications thereof." This invention focuses on microfluidic chips designed to acquire sperms with high velocity and motility. The chip includes an inlet region, a first flow channel, a divergent channel, and one or more outlet regions. It mimics the sperm activation process in the body, allowing for the acquisition of a higher population of motile sperms.
Another significant patent is the "Sperm selecting system and the method thereof." This invention introduces a sperm selecting system that generates a flow field through hydraulic pressure differences. It utilizes the property of sperm swimming against the flow to differentiate them based on vitality. A unique feature of this system is that the sperms are initially set at the entrance of the flow field, rather than at the exit.
Career Highlights
Peng-Chun Chen has worked at Tsinghua University, where he has contributed to research and development in microfluidic technologies. His innovative approaches have garnered attention in the scientific community, particularly for their applications in reproductive health.
Collaborations
He has collaborated with notable colleagues such as Fan-Gang Tseng and Jen-Kuei Wu. Their joint efforts have further advanced the research in microfluidic applications.
Conclusion
Peng-Chun Chen's work in microfluidic technology represents a significant advancement in the field of reproductive science. His patents demonstrate innovative solutions for sperm selection and acquisition, which could lead to improved outcomes in fertility treatments.